{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:26:44Z","timestamp":1791088004434,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.vaccine.2003.08.040","type":"journal-article","created":{"date-parts":[[2003,10,14]],"date-time":"2003-10-14T23:45:58Z","timestamp":1066175158000},"page":"1047-1053","source":"Crossref","is-referenced-by-count":23,"title":["Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines"],"prefix":"10.1016","volume":"22","author":[{"given":"Luis","family":"J\u00f3dar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elwyn","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.08.040_BIB1","unstructured":"Cartwright KAV. Meningococcal disease. In: Cartwright KAV, editor. Meningococcal carriage and disease, vol. 5. Chichester: Wiley; 1995. p. 115\u201346."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture: meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB5","unstructured":"Frasch CE. Meningococcal disease. In: Cartwright KAV, editor. Meningococcal vaccines: past, present and future, vol. 10. Chichester: Wiley; 1995. p. 245\u201384."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus IV. Immunogenicity of group A and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/121.4.372","article-title":"Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man","volume":"121","author":"Artenstein","year":"1970","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB11","unstructured":"World Health Organisation. Requirements for meningococcal polysaccharide vaccine. Technical report series, no. 594. Geneva: World Health Organisation; 1976."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB12","unstructured":"World Health Organisation. Requirements for meningococcal polysaccharide vaccine. Technical report series, no. 626. Geneva: World Health Organisation; 1978. p. 25."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB13","unstructured":"World Health Organisation. Requirements for meningococcal polysaccharide vaccine. Technical report series, no. 658. Geneva: World Health Organisation; 1981. p. 29."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB14","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants","volume":"56","author":"Gold","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB15","first-page":"125","article-title":"Immunisation and the maturation of infant immune responses","volume":"95","author":"Goldblatt","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB16","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0264-410X(98)00097-8","article-title":"Potential and limitations of polysaccharide vaccines in infancy","volume":"16","author":"Cadoz","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.269.2.221","article-title":"Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era","volume":"269","author":"Adams","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB22","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/IAI.69.4.2378-2382.2001","article-title":"Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains","volume":"69","author":"Richmond","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB25","unstructured":"World Health Organisation. Recommendations for the production and control of Hib conjugate vaccines. Technical report series, no. 897. Geneva: World Health Organisation; 2000. p. 27\u201356."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jama.273.11.888","article-title":"Lot-release criteria, postlicensure quality control, and the Haemophilus influenzae type b conjugate vaccines","volume":"273","author":"Egan","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/biol.1999.0175","article-title":"Meeting report: WHO-co-sponsored informal workshop on the use of physicochemical methods for the characterisation of Haemophilus influenzae type b conjugate vaccines","volume":"27","author":"Holliday","year":"1999","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0264-410X(98)00348-X","article-title":"Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines","volume":"17","author":"Costantino","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB30","first-page":"222","article-title":"Glycoconjugate vaccines","volume":"3","author":"Ravenscroft","year":"2000","journal-title":"Current opinion in drug discovery and development"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB31","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/IAI.59.12.4349-4356.1991","article-title":"Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers","volume":"59","author":"Arakere","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1574-695X.2000.tb01475.x","article-title":"Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom","volume":"28","author":"Borrow","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","article-title":"Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults","volume":"18","author":"Richmond","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB34","first-page":"151","article-title":"Structure activity studies on group C meningococcal polysaccharide\u2013protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope","volume":"103","author":"Michon","year":"2000","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/infdis\/139.1.52","article-title":"Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers","volume":"139","author":"Glode","year":"1979","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB36","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0731-7085(02)00462-4","article-title":"Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture","volume":"30","author":"Jones","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB37","unstructured":"World Health Organisation. Requirements for diphtheria, tetanus, pertussis and combined vaccines. WHO technical report series, no. 800. Geneva: World Health Organisation; 1990."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB38","unstructured":"European Pharmacopeoia. Tetanus vaccine (adsorbed). 4th ed. Strasbourg: EDQM; 2002. p. 2216\u20137."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB39","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB40","first-page":"93","article-title":"Characterization of saccharide-CRM197 conjugate vaccines","volume":"103","author":"Hsieh","year":"2000","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB41","first-page":"121","article-title":"Spectroscopic studies of the structure and stability of glycoconjugate vaccines","volume":"103","author":"Jones","year":"2000","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB42","first-page":"35","article-title":"Physicochemical characterisation of the oligosaccharide component of vaccines","volume":"103","author":"Ravenscroft","year":"2000","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB45","first-page":"197","article-title":"Control of meningococcal meningitis with meningococcal vaccines","volume":"48","author":"Artenstein","year":"1975","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0163-4453(88)91907-X","article-title":"Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine","volume":"17","author":"Masterton","year":"1988","journal-title":"J. Infect."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB47","first-page":"357","article-title":"Meningococcal carriage and vaccination in army recruits in Italy","volume":"69","author":"Di Martino","year":"1990","journal-title":"Boll. Ist. Sieroter. (Milan)"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/00365549850160909","article-title":"Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect","volume":"30","author":"Mimouni","year":"1998","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/S0950268800058568","article-title":"Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic","volume":"115","author":"Kriz","year":"1995","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB50","first-page":"407","article-title":"Impact of a mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada","volume":"74","author":"De Wals","year":"1996","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00365540110026638","article-title":"Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine","volume":"33","author":"Pereiro","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1590\/S1413-86702001000600006","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the federal state of Santa Catarina, Brazil","volume":"5","author":"Kupek","year":"2001","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/biol.2000.0253","article-title":"Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines","volume":"28","author":"Jodar","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB54","unstructured":"World Health Organisation. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A\/C vaccines. Geneva: World Health Organisation; 1999."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB55","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB57","doi-asserted-by":"crossref","unstructured":"Jodar L, Stephens D, Feavers IM. Assay parameters and methods of data analysis for comparison of complement sources in the Neisseria meningitidis serogroup C serum bactericidal assay. Biologicals 2002 [in press].","DOI":"10.1006\/biol.2002.0341"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB58","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268899003787","article-title":"Induction of immunological memory in UK infants by a meningococcal A\/C conjugate vaccine","volume":"124","author":"Borrow","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB60","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicentre comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB61","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.275.19.1499","article-title":"Safety and immunogenicity of a serogroups A\/C Neisseria meningitidis oligosaccharide\u2013protein conjugate vaccine in young children. A randomized controlled trial","volume":"275","author":"Lieberman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB62","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/IAI.66.6.2453-2459.1998","article-title":"Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine","volume":"66","author":"Maslanka","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB63","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00008480-199902000-00004","article-title":"Pediatric combination vaccines","volume":"11","author":"Choo","year":"1999","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(88)80684-X","article-title":"Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children","volume":"112","author":"Claesson","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB67","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(05)61789-8","article-title":"Immunogenicity and safety of mixed DTP\/IPV\/Hib vaccines","volume":"349","author":"Schneerson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.08.040_BIB68","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB69","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/00006454-200012000-00003","article-title":"Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B combination vaccine","volume":"19","author":"Greenberg","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00006454-200005000-00006","article-title":"Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis\/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination","volume":"19","author":"Rennels","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria\u2013tetanus\u2013toxoid and acellular pertussis vaccine for primary and for booster immunizations","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.08.040_BIB72","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/324666","article-title":"Immune response of premature infants to meningococcal serogroup C and combined diphtheria\u2013tetanus toxoids\u2013acellular pertussis\u2013Haemophilus influenzae type b conjugate vaccines","volume":"184","author":"Slack","year":"2001","journal-title":"J. Infect. Dis."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T03:06:59Z","timestamp":1585192019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0264410X03006686"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}